by Five Rivers Rx | Nov 20, 2019 | Competition
Product access and pricing are always at the center-point of supply chains–and the healthcare supply chain is no different. Last month, the FTC ruled that Benco Dental Supply Company and Patterson Companies, Inc. violated anti-trust activities. The ruling stemmed from...
by Five Rivers Rx | Nov 6, 2019 | Regulations
The State of Nevada shocked the pharmaceutical supply chain last month by levying an unprecedented $17.4 million in fines due to deficient reporting by drug manufacturers of prescription drugs that are essential for treating diabetes in Nevada. Behind the Fines The...
by Five Rivers Rx | Sep 11, 2019 | VAWD
Background In 2018, legislation was passed in Iowa that required a company to have VAWD Accreditation as a prerequisite to being awarded wholesale drug distribution licensing, in line with three other states. Per an FAQ published October 2018 on the Iowa Board of...
by Five Rivers Rx | Jul 11, 2019 | Regulations
Photo courtesy of the Los Angeles Times Drug pricing has been a huge, very public issue over the past few years. Scandals have touched every part of the pharmacy world – brand drug companies have felt Congress’ wrath, compounding pharmacies are being taken down...
by Five Rivers Rx | Jun 19, 2019 | Regulations
As the changes to state laws per DSCSA continues to sweep the country, the Opioid Epidemic has now also begun to significantly impact the state regulation of the pharmaceutical supply chain. Specifically, state governments have pointed the blame of the Opioid Epidemic...
